Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies

Published:2014-09 Issue:9 Volume:19 Page:1394-1401
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

‘t Hart Bert A.,Jagessar S. Anwar,Kap Yolanda S.,Haanstra Krista G.,Philippens Ingrid H.C.H.M.,Serguera Che,Langermans Jan,Vierboom Michel

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference62 articles.

1. Novel therapeutic strategies for multiple sclerosis: a multifaceted adversary;Lopez-Diego;Nat. Rev. Drug Discov.,2008

2. Perspective: transforming science into medicine: how clinician–scientists can build bridges across research's ‘valley of death’;Roberts;Acad. Med.,2012

3. Into the valley of death: research to innovation;Hudson;Drug Discov. Today,2013

4. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat. Rev. Drug Discov.,2004

5. Failure is an option: learning from unsuccessful proof-of-concept trials;Schafer;Drug Discov. Today,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding new analgesics: Computational pharmacology faces drug discovery challenges;Biochemical Pharmacology;2024-04

2. An Unexpected Symbiosis of Animal Welfare and Clinical Relevance in a Refined Nonhuman Primate Model of Human Autoimmune Disease;Nonhuman Primate Welfare;2023

3. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis;Journal of Neuroinflammation;2022-11-19

4. Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis;2022-08-23

5. Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?;Frontiers in Immunology;2022-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3